These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25875117)

  • 1. Ex vivo cytosolic delivery of functional macromolecules to immune cells.
    Sharei A; Trifonova R; Jhunjhunwala S; Hartoularos GC; Eyerman AT; Lytton-Jean A; Angin M; Sharma S; Poceviciute R; Mao S; Heimann M; Liu S; Talkar T; Khan OF; Addo M; von Andrian UH; Anderson DG; Langer R; Lieberman J; Jensen KF
    PLoS One; 2015; 10(4):e0118803. PubMed ID: 25875117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated delivery of siRNAs for anti-HIV therapy.
    Kim SS; Subramanya S; Peer D; Shimaoka M; Shankar P
    Methods Mol Biol; 2011; 721():339-53. PubMed ID: 21431696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Low-Backpressure Single-Cell Point Constriction for Cytosolic Delivery Based on Rapid Membrane Deformations.
    Xing X; Pan Y; Yobas L
    Anal Chem; 2018 Feb; 90(3):1836-1844. PubMed ID: 29308899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells.
    Chen J; Ellert-Miklaszewska A; Garofalo S; Dey AK; Tang J; Jiang Y; Clément F; Marche PN; Liu X; Kaminska B; Santoni A; Limatola C; Rossi JJ; Zhou J; Peng L
    Nat Protoc; 2021 Jan; 16(1):327-351. PubMed ID: 33277630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles.
    Ramishetti S; Kedmi R; Goldsmith M; Leonard F; Sprague AG; Godin B; Gozin M; Cullis PR; Dykxhoorn DM; Peer D
    ACS Nano; 2015 Jul; 9(7):6706-16. PubMed ID: 26042619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Type Preference of a Novel Human Derived Cell-Permeable Peptide dNP2 and TAT in Murine Splenic Immune Cells.
    Lim S; Lee JA; Koo JH; Kang TG; Ha SJ; Choi JM
    PLoS One; 2016; 11(5):e0155689. PubMed ID: 27186978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.
    Song XT; Evel-Kabler K; Rollins L; Aldrich M; Gao F; Huang XF; Chen SY
    PLoS Med; 2006 Jan; 3(1):e11. PubMed ID: 16381597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modular platform for targeted RNAi therapeutics.
    Kedmi R; Veiga N; Ramishetti S; Goldsmith M; Rosenblum D; Dammes N; Hazan-Halevy I; Nahary L; Leviatan-Ben-Arye S; Harlev M; Behlke M; Benhar I; Lieberman J; Peer D
    Nat Nanotechnol; 2018 Mar; 13(3):214-219. PubMed ID: 29379205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vector-free microfluidic platform for intracellular delivery.
    Sharei A; Zoldan J; Adamo A; Sim WY; Cho N; Jackson E; Mao S; Schneider S; Han MJ; Lytton-Jean A; Basto PA; Jhunjhunwala S; Lee J; Heller DA; Kang JW; Hartoularos GC; Kim KS; Anderson DG; Langer R; Jensen KF
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2082-7. PubMed ID: 23341631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in siRNA delivery.
    Sarisozen C; Salzano G; Torchilin VP
    Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivering antiviral siRNA into human T-cells: New approaches in RNAi-based HIV therapy.
    Ban HS; Lee SK; Kumar P
    IDrugs; 2009 Dec; 12(12):774-8. PubMed ID: 19943220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages.
    Banerjea A; Li MJ; Bauer G; Remling L; Lee NS; Rossi J; Akkina R
    Mol Ther; 2003 Jul; 8(1):62-71. PubMed ID: 12842429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SiRNA In Vivo-Targeted Delivery to Murine Dendritic Cells by Oral Administration of Recombinant Yeast.
    Xu K; Liu Z; Zhang L; Zhang T; Zhang Z
    Methods Mol Biol; 2016; 1364():165-81. PubMed ID: 26472450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.
    Adesina SK; Akala EO
    Mol Pharm; 2015 Dec; 12(12):4175-87. PubMed ID: 26524196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice.
    Schoellhammer CM; Lauwers GY; Goettel JA; Oberli MA; Cleveland C; Park JY; Minahan D; Chen Y; Anderson DG; Jaklenec A; Snapper SB; Langer R; Traverso G
    Gastroenterology; 2017 Apr; 152(5):1151-1160. PubMed ID: 28088460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV replication through siRNA carried by CXCR4-targeted chimeric nanobody.
    Cunha-Santos C; Perdigao PRL; Martin F; Oliveira JG; Cardoso M; Manuel A; Taveira N; Goncalves J
    Cell Mol Life Sci; 2020 Jul; 77(14):2859-2870. PubMed ID: 31641784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell-specific siRNA delivery using antibody-conjugated chitosan nanoparticles.
    Lee J; Yun KS; Choi CS; Shin SH; Ban HS; Rhim T; Lee SK; Lee KY
    Bioconjug Chem; 2012 Jun; 23(6):1174-80. PubMed ID: 22607555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
    Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
    ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of siRNA Nanosheets for Efficient RNA Interference.
    Kim H; Lee JS; Lee JB
    Sci Rep; 2016 Apr; 6():25146. PubMed ID: 27120975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
    Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
    Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.